PRAX vs STZ · $7.38B cap vs P/E 14, rev $9.14B
Praxis Precision Medicines Inc (PRAX) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
PRAX currently screens at market cap $7.38B. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the PRAX and STZ stock pages for the full models.
Not investment advice.